Actions to Address the Rising Costs of Prescription Drugs – New Report and Briefing Nov. 30

Over the past several decades, the biopharmaceutical sector in the United States has been successful in developing and delivering effective drugs for improving health and fighting disease, and many medical conditions that were long deemed untreatable can now be cured or managed effectively.  At the same time, spending on prescription drugs has been rising dramatically, to the point that many individuals have difficulty paying for the drugs that they or their family members need.  Drug costs are now a significant part of the nation's total spending on health care.

A new report from the National Academies of Sciences, Engineering, and Medicine recommends a number of actions aimed at improving the affordability of prescription drugs in the U.S. without discouraging the development of new and more effective drugs for the future. It looks specifically at areas such as drug pricing, entry of generics and biosimilars into the market, financial transparency in the supply chain, and insurance benefit designs.

The report will be released at a public briefing on Nov. 30 to be moderated by Donna Leinwand Leger, managing editor of USA Today. Participating members of the committee that wrote the report:

Those who cannot attend the briefing in person may watch a live webcast here.  Follow the conversation on social media using #NASEMaffordabledrugs.

Advance copies of Making Medicines Affordable: A National Imperative will be available to reporters only beginning at 3 p.m. EST on Wednesday, Nov. 29. The report is embargoed and not for public release before 1:00 p.m. EST on Thursday, Nov. 30. The public briefing will begin at 1:00 p.m. EST on Nov. 30 in the Fourth Estate Room at the National Press Club, 529 14th St. N.W., 13th Floor, Washington, D.C.  Reporters who wish to attend the briefing or obtain a copy of the report should contact the Office of News and Public Information at tel. 202-334-2138 or e-mail